Absence of the MGMT protein as well as methylation of the MGMT promoter predict the sensitivity for temozolomide

被引：0
|
作者：
K A van Nifterik
J van den Berg
W F van der Meide
N Ameziane
L E Wedekind
R D M Steenbergen
S Leenstra
M V M Lafleur
B J Slotman
L J A Stalpers
P Sminia
机构：
[1] VU University Medical Center,Department of Radiation Oncology
[2] VU University Medical Center,Department of Pathology
[3] VU University Medical Center,Department of Clinical Genetics
[4] St Elisabeth Ziekenhuis,Department of Neurosurgery
[5] Academic Medical Center,Department of Radiotherapy
来源：
British Journal of Cancer | 2010年 / 103卷
关键词：
MGMT; temozolomide; glioma; prediction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：29 / 35
页数：6
相关论文
共 50 条
  • [21] MGMT promoter methylation in glioblastoma
    Santosh, Vani
    Sravya, P.
    NEUROLOGY INDIA, 2018, 66 (04) : 1115 - 1116
  • [22] The MGMT promoter SNP rs16906252 is a risk factor for MGMT methylation in glioblastoma and is predictive of response to temozolomide
    Rapkins, Robert W.
    Wang, Fan
    Nguyen, HuyTram N.
    Cloughesy, Timothy F.
    Lai, Albert
    Ha, Wendy
    Nowak, Anna K.
    Hitchins, Megan P.
    McDonald, Kerrie L.
    NEURO-ONCOLOGY, 2015, 17 (12) : 1589 - 1598
  • [23] MGMT gene promotor methylation does not predict temozolomide response in melanoma
    Hassel, J. C.
    Sucker, A.
    Edler, L.
    Rausch, R.
    Kurzen, H.
    Moll, I.
    Stresemann, C.
    Lyko, F.
    Spieth, K.
    Egberts, F.
    Dummer, R.
    Schadendorf, D.
    EXPERIMENTAL DERMATOLOGY, 2009, 18 (03) : 301 - 301
  • [24] TERT PROMOTER MUTATION AND MGMT PROMOTER METHYLATION-MEDIATED SENSITIVITY TO TEMOZOLOMIDE IN IDH-WILDTYPE GLIOBLASTOMA: IS THERE A LINK?
    Gramatzki, Dorothee
    Felsberg, Joerg
    Hentschel, Bettina
    Wolter, Marietta
    Schackert, Gabriele
    Westphal, Manfred
    Regli, Luca
    Thon, Niklas
    Tatagiba, Marcos
    Wick, Wolfgang
    Schlegel, Uwe
    Krex, Dietmar
    Matschke, Jakob
    Roth, Patrick
    Suresh, Marian
    Kamp, Marcel
    Rushing, Elisabeth
    Pietsch, Torsten
    von Deimling, Andreas
    Sabel, Michael
    Loeffler, Markus
    Weller, Michael
    Reifenberger, Guido
    NEURO-ONCOLOGY, 2020, 22 : 14 - 14
  • [25] Activity of temozolomide in patients with advanced chemorefractory colorectal cancer and MGMT promoter methylation
    Pietrantonio, F.
    Perrone, F.
    de Braud, F.
    Castano, A.
    Maggi, C.
    Bossi, I.
    Gevorgyan, A.
    Biondani, P.
    Pacifici, M.
    Busico, A.
    Gariboldi, M.
    Festinese, F.
    Tamborini, E.
    Di Bartolomeo, M.
    ANNALS OF ONCOLOGY, 2014, 25 (02) : 404 - 408
  • [26] The Impact of MGMT Promoter Methylation and Temozolomide Treatment in Serbian Patients with Primary Glioblastoma
    Jovanovic, Nikola
    Mitrovic, Tatjana
    Cvetkovic, Vladimir J.
    Tosic, Svetlana
    Vitorovic, Jelena
    Stamenkovic, Slavisa
    Nikolov, Vesna
    Kostic, Aleksandar
    Vidovic, Natasa
    Krstic, Miljan
    Jevtovic-Stoimenov, Tatjana
    Pavlovic, Dusica
    MEDICINA-LITHUANIA, 2019, 55 (02):
  • [27] Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy
    J Dunn
    A Baborie
    F Alam
    K Joyce
    M Moxham
    R Sibson
    D Crooks
    D Husband
    A Shenoy
    A Brodbelt
    H Wong
    T Liloglou
    B Haylock
    C Walker
    British Journal of Cancer, 2009, 101 : 124 - 131
  • [28] Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy
    Dunn, J.
    Baborie, A.
    Alam, F.
    Joyce, K.
    Moxham, M.
    Sibson, R.
    Crooks, D.
    Husband, D.
    Shenoy, A.
    Brodbelt, A.
    Wong, H.
    Liloglou, T.
    Haylock, B.
    Walker, C.
    BRITISH JOURNAL OF CANCER, 2009, 101 (01) : 124 - 131
  • [29] Selinexor synergizes with temozolomide in preclinical models of glioblastoma independent of MGMT promoter methylation
    Henegar, Leah
    Chang, Hua
    Walker, Christopher J.
    Kashyap, Trinayan
    Maloof, Marie
    Wang, Feng
    Martyn, Kathleen
    Orr, Shira
    Tamir, Sharon
    Kauffman, Michael G.
    Shacham, Sharon
    Landesman, Yosef
    CANCER RESEARCH, 2022, 82 (12)
  • [30] A Novel DNA Methylation-Based Signature Can Predict the Responses of MGMT Promoter Unmethylated Glioblastomas to Temozolomide
    Chai, Rui-Chao
    Chang, Yu-Zhou
    Wang, Qiang-Wei
    Zhang, Ke-Nan
    Li, Jing-Jun
    Huang, Hua
    Wu, Fan
    Liu, Yu-Qing
    Wang, Yong-Zhi
    FRONTIERS IN GENETICS, 2019, 10
12345